Beyond Publication Bias Publication Beyond Publication Bias In drug development, clinical medicine, or health policy making, basing one's decisions on a selective…Certara2011 年 5 月 1 日
The Development of UGT1A1 and 1A6 in the Pediatric Liver Publication The Development of UGT1A1 and 1A6 in the Pediatric Liver UDP-glucuronosyltransferases (UGTs) are critical for the metabolism and clearance of drugs, chemicals, and hormones. The…Certara2011 年 5 月 1 日
Towards a Better Prediction of Peak Concentration, Volume of Distribution, and Half-life After Oral Drug Administration in Man, Using Allometry Publication Towards a Better Prediction of Peak Concentration, Volume of Distribution, and Half-life After Oral Drug Administration in Man, Using Allometry It is imperative that new drugs demonstrate adequate pharmacokinetic properties, allowing an optimal safety margin…Certara2011 年 5 月 1 日
Pharmacokinetics of Clofarabine in Patients with High-risk Inherited Metabolic Disorders Undergoing Brain-sparing Hematopoietic Cell Transplantation Publication Pharmacokinetics of Clofarabine in Patients with High-risk Inherited Metabolic Disorders Undergoing Brain-sparing Hematopoietic Cell Transplantation Clofarabine, a newer purine analog with reduced central nervous system toxicity, may prove advantageous in…Certara2011 年 5 月 1 日
Estimating Toxicity-related Biological Pathway Altering Doses for High-throughput Chemical Risk Assessment Publication Estimating Toxicity-related Biological Pathway Altering Doses for High-throughput Chemical Risk Assessment We describe a framework for estimating the human dose at which a chemical significantly alters…Certara2011 年 4 月 18 日
Pharmacokinetics and Pharmacodynamics of TBR-652, a Novel CCR5 Antagonist, in HIV-1-Infected, Antiretroviral Treatment-experienced and CCR5 Antagonist-naive Patients Publication Pharmacokinetics and Pharmacodynamics of TBR-652, a Novel CCR5 Antagonist, in HIV-1-Infected, Antiretroviral Treatment-experienced and CCR5 Antagonist-naive Patients TBR-652 is a novel CCR5 antagonist with potent in vitro anti-HIV activity. The objective of…Certara2011 年 4 月 12 日
In Silico Prediction of Efavirenz and Rifampicin Drug-drug Interaction Considering Weight and CYP2B6 Phenotype Publication In Silico Prediction of Efavirenz and Rifampicin Drug-drug Interaction Considering Weight and CYP2B6 Phenotype This study aimed to test whether a pharmacokinetic simulation model could extrapolate nonclinical drug data…Certara2011 年 4 月 1 日
Systematic Review: Diagnostic Accuracy of Clinical Decision Rules for Venous Thromboembolism in Elderly Publication Systematic Review: Diagnostic Accuracy of Clinical Decision Rules for Venous Thromboembolism in Elderly Physicians committed to the care of elderly patients are challenged with the diagnosis of venous…Certara2011 年 4 月 1 日
Sources of Interindividual Variability in IVIVE of Clearance: An Investigation into the Prediction of Benzodiazepine Clearance Using a Mechanistic Population-based Pharmacokinetic Model Publication Sources of Interindividual Variability in IVIVE of Clearance: An Investigation into the Prediction of Benzodiazepine Clearance Using a Mechanistic Population-based Pharmacokinetic Model Prediction of metabolic clearance in extreme individuals rather than the 'average human' is becoming an…Certara2011 年 3 月 24 日
Is a Monte Carlo Simulation an Exotic Drink? 知识库 Is a Monte Carlo Simulation an Exotic Drink? The term “Monte Carlo simulation” is often used in the modeling and simulation literature with…Certara2011 年 3 月 21 日